Skip to main content
OpenTrials

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,331 public trials 1,293 recruiting studies
Refine in advanced search Browse all conditions

Liver Diseases trial results

Recruiting

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

NCT07221188

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • GSK Investigational Site Arcadia, California, United States
  • GSK Investigational Site Covina, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site San Diego, California, United States
View all 53 locations
View Trial Details
Recruiting

A Study in Adults to Learn About Inherited Alpha-1 Antitrypsin Deficiency (AATD) and AATD Related Liver Problems

NCT06512454

Conditions
Alpha1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • University of Florida Gainesville, Florida, United States
  • University of South Carolina Charleston, South Carolina, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
  • Vienna General Hospital (AKH Wien) Vienna, Austria
View Trial Details
Recruiting

Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial

NCT06811116

Conditions
Adenocarcinoma, Advanced Hepatocellular Carcinoma, Carcinoma, +12 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
View Trial Details
Recruiting

IDOV-Immune for Advanced Solid Tumors

NCT06910657

Conditions
Adenocarcinoma, Adnexal Diseases, Adrenal Gland Diseases, +94 more
Locations
  • Washington University School of Medicine St Louis, Missouri, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • South Texas Accelerated Research Therapeutics San Antonio, Texas, United States
  • Westmead Hospital Westmead, New South Wales, Australia
View Trial Details
Recruiting

A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

NCT07291076

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Local Institution - 0137 Duarte, California, United States
  • Local Institution - 0070 Los Angeles, California, United States
  • Local Institution - 0107 Chicago, Illinois, United States
  • Local Institution - 0134 Detroit, Michigan, United States
View all 64 locations
View Trial Details
Recruiting

FOG-001 in Locally Advanced or Metastatic Solid Tumors

NCT05919264

Conditions
Adamantinomatous Craniopharyngioma, Adenocarcinoma, Adenoma, +65 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Honor Health Scottsdale, Arizona, United States
  • Arizona Cancer Center at University of Arizona Tucson, Arizona, United States
  • University of California, Los Angeles (UCLA) Los Angeles, California, United States
View all 33 locations
View Trial Details

Related conditions